Skip To Main Content
M. Muzaffer Değertekin on Muck Rack

M. Muzaffer Değertekin

As seen in: Heart, Lung and Circulation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with M. Muzaffer

Contact M. Muzaffer, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Evaluation of Asymmetric Dimethylarginine Levels in Patients With Chronic Thromboembolic Pulmonary Hypertension Undergoing Pulmonary Endarterectomy

|
By Ayça Türer Cabbar, M. Muzaffer Değertekin, Mustafa A. Şimşek, Olcay Özveren
| Heart, Lung and Circulation Verified
Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a form of pulmonary embolism, and pulmonary endarterectomy (PEA) is the surgical treatment. Asymmetric dimethylarginine (ADMA) levels are increased in pulmonary hypertension. This study aimed to investigate serum ADMA levels in patients with CTEPH, the effect of PEA on ADMA, and its prognostic value in long-term mortality. Method Eighty (80) patients with CTEPH and 32 healthy controls were included.
Open in Who Shared Issue with article?
See all 1 articles